Tag Archives: PSTI

Top 10 Medical Stocks To Invest In 2019

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €107.00 ($124.42) price target from equities researchers at HSBC in a note issued to investors on Tuesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.04% from the stock’s current price.

FME has been the subject of several other reports. JPMorgan Chase & Co. set a €96.10 ($111.74) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, July 26th. Barclays set a €90.00 ($104.65) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Friday, May 4th. Berenberg Bank set a €100.80 ($117.21) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Tuesday, July 31st. Credit Suisse Group set a €91.00 ($105.81) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Tuesday, July 31st. Finally, Commerzbank set a €82.00 ($95.35) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Tuesday, July 31st. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of €95.23 ($110.73).

Top 10 Medical Stocks To Invest In 2019: SteadyMed Ltd.(STDY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Steadymed Ltd (NASDAQ:STDY) CEO Jonathan Rigby sold 88,831 shares of the company’s stock in a transaction on Friday, August 17th. The stock was sold at an average price of $4.66, for a total transaction of $413,952.46. Following the completion of the sale, the chief executive officer now owns 41,605 shares of the company’s stock, valued at $193,879.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Top 10 Medical Stocks To Invest In 2019: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    It’s another disappointing day for one of America’s top biotech companies. Gilead Sciences Inc.’s (NASDAQ: GILD) selonsertib failed to improve fibrosis in the Phase 3 STELLAR-4 trial, and its shares traded lower as a result. While this is more bad news for Gilead, it may prove to be great news for Intercept Pharmaceuticals Inc. (NASDAQ: ICPT).

  • [By Max Byerly]

    JMP Securities upgraded shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from a market perform rating to an outperform rating in a research report report published on Wednesday morning, Marketbeat.com reports. JMP Securities currently has $175.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $75.00.

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

Top 10 Medical Stocks To Invest In 2019: Phillips 66(PSX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Refining giant Phillips 66 (NYSE:PSX) and Canadian energy infrastructure behemoth Enbridge (NYSE:ENB) initially pitched Gray Oak to oil shippers in early December. At the time, they envisioned a 385,000 barrel-a-day pipeline that would move crude from several connection points in West Texas to refineries and export docks along the Texas coast starting in the second half of 2019.

  • [By Reuben Gregg Brewer]

    In January, oil and natural gas refinery Valero Energy Corporation’s (NYSE:VLO) shares jumped 17%, according to data provided by S&P Global Market Intelligence. That was the biggest gain of this trio, but Marathon Petroleum Corp. (NYSE:MPC) and its 12% gain wasn’t far behind. Even Phillips 66 (NYSE:PSX) got in the act with a nearly 11% gain. All of them beat the roughly 8% rise in the S&P 500 index.

  • [By Max Byerly]

    Phillips 66 (NYSE: PSX) and Vertex Energy (NASDAQ:VTNR) are both oils/energy companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

  • [By Shane Hupp]

    HPM Partners LLC grew its position in Phillips 66 (NYSE:PSX) by 10.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,411 shares of the oil and gas company’s stock after buying an additional 1,059 shares during the period. HPM Partners LLC’s holdings in Phillips 66 were worth $1,282,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Payden & Rygel lifted its stake in shares of Phillips 66 (NYSE:PSX) by 46.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 199,700 shares of the oil and gas company’s stock after buying an additional 63,100 shares during the quarter. Phillips 66 makes up approximately 1.6% of Payden & Rygel’s portfolio, making the stock its 25th biggest position. Payden & Rygel’s holdings in Phillips 66 were worth $19,155,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In 2019: Altisource Residential Corporation(RESI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Front Yard Residential Corp (NYSE:RESI) was the target of some unusual options trading activity on Thursday. Traders bought 3,877 put options on the company. This is an increase of approximately 899% compared to the average volume of 388 put options.

  • [By Logan Wallace]

    Vonovia SE Depository Receipt (NYSE: RESI) and Front Yard Residential (NYSE:RESI) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

  • [By Logan Wallace]

    Front Yard Residential (NYSE:RESI) issued its quarterly earnings data on Tuesday. The real estate investment trust reported ($0.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.02), Morningstar.com reports. Front Yard Residential had a negative return on equity of 25.77% and a negative net margin of 196.93%.

Top 10 Medical Stocks To Invest In 2019: VOC Energy Trust(VOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Deutsche Bank AG reduced its position in VOC Energy Trust (NYSE:VOC) by 64.5% in the 4th quarter, Holdings Channel reports. The firm owned 19,000 shares of the oil and gas producer’s stock after selling 34,500 shares during the period. Deutsche Bank AG’s holdings in VOC Energy Trust were worth $112,000 as of its most recent filing with the SEC.

Top 10 Medical Stocks To Invest In 2019: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Encana (NYSE:ECA) (TSE:ECA) had its target price raised by Morgan Stanley from $16.00 to $20.00 in a research report report published on Wednesday morning. Morgan Stanley currently has a buy rating on the oil and gas company’s stock.

  • [By Stephan Byrd]

    Cenovus Energy (NYSE:CVE) and Encana (NYSE:ECA) are both large-cap oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

  • [By Max Byerly]

    Here are some of the news stories that may have effected Accern Sentiment’s rankings:

    Get Encana alerts:

    Encana Corp (ECA) Rising Higher 7.95% Over the Past Four Weeks (fisherbusinessnews.com) Encana Corporation (ECA) Most Active Stock Price trades 19.10% off from 200- SMA (nasdaqchronicle.com) Mid-Day Movers –: Encana Corporation (NYSE:ECA), CSX Corporation (NASDAQ:CSX), MGIC Investment Corporation … (journalfinance.net) Featured Stock: Encana Corporation (ECA) (stockquote.review) Active Stock Evaluation – Encana Corporation (NYSE: ECA) (financerater.com)

    ECA has been the subject of a number of research analyst reports. Morgan Stanley raised shares of Encana from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $15.00 to $18.00 in a report on Wednesday, January 24th. Evercore ISI raised shares of Encana from an “in-line” rating to an “outperform” rating and upped their price target for the company from $10.84 to $16.00 in a report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Encana from a “hold” rating to a “sell” rating in a report on Wednesday, January 31st. Scotiabank raised shares of Encana from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $13.00 to $14.00 in a report on Friday, February 16th. Finally, Goldman Sachs cut their price target on shares of Encana from $17.25 to $14.00 and set a “buy” rating for the company in a report on Friday, April 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $15.28.

  • [By Ethan Ryder]

    Electra (CURRENCY:ECA) traded down 22.1% against the dollar during the 1 day period ending at 11:00 AM Eastern on August 14th. One Electra coin can currently be purchased for approximately $0.0004 or 0.00000007 BTC on cryptocurrency exchanges including Cryptohub, CryptoBridge, Cryptopia and Novaexchange. In the last seven days, Electra has traded 36.7% lower against the dollar. Electra has a total market capitalization of $11.78 million and approximately $119,848.00 worth of Electra was traded on exchanges in the last day.

Top 10 Medical Stocks To Invest In 2019: ProShares UltraShort Nasdaq Biotechnology(BIS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Bismuth (BIS) uses the hashing algorithm. Its genesis date was May 1st, 2017. Bismuth’s total supply is 11,579,876 coins and its circulating supply is 11,011,069 coins. The Reddit community for Bismuth is /r/cryptobismuth and the currency’s Github account can be viewed here. The official message board for Bismuth is bismuth.cz/forum. Bismuth’s official Twitter account is @cryptobismuth and its Facebook page is accessible here. The official website for Bismuth is bismuth.cz.

  • [By Ethan Ryder]

    Bismuth (BIS) uses the hashing algorithm. Its launch date was May 1st, 2017. Bismuth’s total supply is 10,193,595 coins and its circulating supply is 9,644,979 coins. The Reddit community for Bismuth is /r/cryptobismuth and the currency’s Github account can be viewed here. The official website for Bismuth is bismuth.cz. Bismuth’s official Twitter account is @cryptobismuth and its Facebook page is accessible here. The official message board for Bismuth is bismuth.cz/forum.

  • [By Shane Hupp]

    News articles about ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) have trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ProShares UltraShort Nasdaq Biotechnology earned a news impact score of 0.15 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.2593843139852 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Bismuth (CURRENCY:BIS) traded 8.1% lower against the US dollar during the 24-hour period ending at 21:00 PM ET on June 17th. Bismuth has a total market cap of $14.34 million and $48,199.00 worth of Bismuth was traded on exchanges in the last day. One Bismuth coin can now be purchased for $1.35 or 0.00020851 BTC on major exchanges including Cryptopia and Octaex. During the last week, Bismuth has traded down 8.5% against the US dollar.

Top 10 Medical Stocks To Invest In 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

Top 10 Medical Stocks To Invest In 2019: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Shane Hupp]

    FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.

    Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).

Top 10 Medical Stocks To Invest In 2019: PetMed Express, Inc.(PETS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about Petmed Express (NASDAQ:PETS) have been trending somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Petmed Express earned a news impact score of 0.05 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 47.0051994773148 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Steve Symington]

    Nevertheless, several individual stocks failed to keep up. Read on to see why CTI BioPharma (NASDAQ:CTIC), PetMed Express (NASDAQ:PETS), and Pfizer (NYSE:PFE) each slumped today.

  • [By Jason Hall, George Budwell, and Daniel Miller]

    For instance, TerraForm Power Inc. (NASDAQ:TERP) is easy to miss because it operates in what’s still something of a niche: owning renewable energy projects and selling the electricity to utilities and industrial users. Then you have Stanley Black & Decker, Inc. (NYSE:SWK), the company behind a handful of relatively well-known tool brands but not one that’s widely known among investors. It can get even more obscure, like Petmed Express Inc. (NASDAQ:PETS), the online pet pharmacy that’s certainly not a household name for most people and certainly not investors. 

  • [By Logan Wallace]

    Petmed Express Inc (NASDAQ:PETS) has received an average rating of “Hold” from the nine research firms that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $39.00.

  • [By ]

    PetMed Express (PETS) : “No, no, no, no. When we want pet drugs, we want Idexx Laboratories (IDXX) .”

    Xerox (XRX) : “I’d sell Xerox. That’s a house of pain.”

  • [By Timothy Green, Tyler Crowe, and Sean Williams]

    Three of our Motley Fool contributors want you to know about A.O. Smith (NYSE:AOS), Kulicke & Soffa Industries (NASDAQ:KLIC), and PetMed Express (NASDAQ:PETS). Read on to find out why these unknown but amazing dividend stocks belong in your portfolio.

Hot Value Stocks To Own Right Now

Palo Alto Networks (NYSE:PANW) had its target price raised by Credit Suisse Group from $150.00 to $175.00 in a report released on Tuesday morning. They currently have an underweight rating on the network technology company’s stock.

PANW has been the subject of a number of other research reports. Robert W. Baird lifted their price objective on shares of Palo Alto Networks from $190.00 to $216.00 and gave the company a neutral rating in a report on Tuesday. Deutsche Bank lifted their price objective on shares of Palo Alto Networks from $180.00 to $210.00 and gave the company a buy rating in a report on Tuesday, February 27th. ValuEngine upgraded shares of Palo Alto Networks from a hold rating to a buy rating in a report on Monday, April 2nd. Susquehanna Bancshares upgraded shares of Palo Alto Networks from a neutral rating to a positive rating and dropped their price objective for the company from $150.00 to $145.00 in a report on Wednesday, February 21st. Finally, KeyCorp lifted their price objective on shares of Palo Alto Networks from $170.00 to $190.00 and gave the company an overweight rating in a report on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and thirty-seven have issued a buy rating to the stock. The company has an average rating of Buy and a consensus target price of $198.68.

Hot Value Stocks To Own Right Now: Frequency Electronics Inc.(FEIM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Frequency Electronics (NASDAQ:FEIM) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Frequency Electronics earned a news impact score of 0.15 on Accern’s scale. Accern also assigned media headlines about the communications equipment provider an impact score of 46.4556074629456 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Hot Value Stocks To Own Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks To Own Right Now: Nuance Communications Inc.(NUAN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Nuance Communications (NASDAQ:NUAN) had its price objective cut by Stifel Nicolaus from $18.00 to $15.00 in a report issued on Thursday. The brokerage currently has a “hold” rating on the software maker’s stock. Stifel Nicolaus’ target price indicates a potential upside of 15.03% from the company’s current price.

  • [By Dan Caplinger]

    One key part of the rush toward artificial intelligence is making sure that automated systems can communicate easily and effectively with their human users. Nuance Communications (NASDAQ:NUAN) has a huge head start in voice recognition technology, and despite its successes in areas like medical transcription, the tech company knows that in order to sustain its competitive advantage, it needs to use its lead to push forward with groundbreaking technological innovations.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Ethan Ryder]

    Shares of Nuance Communications Inc. (NASDAQ:NUAN) have been assigned a consensus recommendation of “Buy” from the twelve brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $20.25.

  • [By Paul Ausick]

    Nuance Communications Inc. (NASDAQ: NUAN) dropped about 20% Thursday to post a new 52-week low of $12.19. Shares closed at $15.28 on Wednesday and the stock’s 52-week high is $19.49. Volume of around 19 million shares was about nine times the daily average. The company reported indifferent results Wednesday night but cut its outlook for revenue growth.

Hot Value Stocks To Own Right Now: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Chris Lange]

    GTx Inc. (NASDAQ: GTXI) will present additional data demonstrating duration of response following completion of treatment for its Phase 2 proof-of-concept clinical trial evaluating enobosarm 3 mg in postmenopausal women with stress urinary incontinence at the upcoming 2018 American Urological Association meeting on May 18.

  • [By Stephan Byrd]

    GTx, Inc. (NASDAQ:GTXI) was down 6.4% during mid-day trading on Friday after an insider sold shares in the company. The company traded as low as $17.10 and last traded at $17.30. Approximately 726,400 shares traded hands during trading, an increase of 492% from the average daily volume of 122,740 shares. The stock had previously closed at $18.49.

  • [By Ethan Ryder]

    GTx, Inc. (NASDAQ:GTXI) insider Jason T. Shackelford sold 9,279 shares of the business’s stock in a transaction dated Wednesday, June 20th. The stock was sold at an average price of $19.01, for a total transaction of $176,393.79. Following the sale, the insider now directly owns 19,453 shares in the company, valued at $369,801.53. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Hot Value Stocks To Own Right Now: Brandywine Realty Trust(BDN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Brandywine Realty Trust (NYSE:BDN) by 5.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 168,439 shares of the real estate investment trust’s stock after buying an additional 8,253 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.09% of Brandywine Realty Trust worth $2,675,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Brandywine Realty Trust (BDN) Issues FY18 Earnings Guidance” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at www.tickerreport.com/banking-finance/3371791/brandywine-realty-trust-bdn-issues-fy18-earnings-guidance.html.

  • [By Ethan Ryder]

    BNP Paribas Arbitrage SA raised its stake in Brandywine Realty Trust (NYSE:BDN) by 18.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 37,507 shares of the real estate investment trust’s stock after buying an additional 5,861 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Brandywine Realty Trust were worth $596,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Brandywine Realty Trust (BDN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Brandywine Realty Trust (NYSE:BDN) has received an average rating of “Hold” from the nine analysts that are presently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $18.00.

Top Performing Stocks For 2019

The S&P 500 is up nearly 7% year-to-date, but the average stock in the index is up just 5.70%. This means the largest stocks in the cap-weighted index are outperforming the smallest names. Even still, two-thirds of the stocks in the S&P are up year-to-date, while 35% of stocks are up more than 10%. Seventy stocks are up more than 20%, while just 25 are up more than 30%.

Below is a list of the 30 best performing S&P 500 stocks year-to-date. As shown, Vertex Pharma (NASDAQ:VRTX) is up the most with a gain of 55%, followed by Activision Blizzard (NASDAQ:ATVI), Arconic (NYSE:ARNC), CSX and Lam Research (NASDAQ:LRCX). Wynn Resorts (NASDAQ:WYNN) a Bespoke Model Portfolio name ranks 7th best with a gain of 40.8%, while Adobe (NASDAQ:ADBE) another Bespoke Model Portfolio name ranks 18th with a gain of 31.7%. Apple (NASDAQ:AAPL) ranks just behind ADBE at 31.68%. As the largest stock in the world with a market cap of just under $800 billion, Apples gain this year has been a huge contributor to the cap-weighted S&P 500. Another mega-cap tech name thats up more than 30% YTD is Facebook (NASDAQ:FB). Coach (NYSE:COH) may be the most surprising name on the list in the 29th spot, given the pain that retail stocks have gone through. But remember, since Coach is a retailer that has its own brand, its not part of our Death By Amazon (DBA) index of retailers that rely mostly on third party brands. Thats where the real pain is.

Top Performing Stocks For 2019: General Motors Company(GM)

Advisors’ Opinion:

  • [By John Rosevear]

    Of course, Intel’s decision might depend on whether other major automakers with advanced self-driving programs, like General Motors (NYSE:GM), choose to join the Alliance. We’ll see how this plays out — but either way, if you’re eyeing investment opportunities in and around the race to deploy self-driving vehicles, I think it’s worth putting Aquantia on your radar.

  • [By Jeremy Bowman]

    The industry uses a five-level scale to measure autonomous vehicle capabilities.

    Level Zero — No Automation:The driver performs all tasks. Level One — Driver Assistance:Vehicle assists with features like adaptive cruise control, which can slow down the car according to traffic, or lane keep assist, which keeps the car inside highway lanes. However, the driver still must be in control of the car. Level Two — Partial Automation:At level two, the car can help control speed and steering, helping with spacing in between cars and centering in lanes. Some examples of level two automation includeTeslaautopilot,VolvoPilot Assist, andAudiTraffic Jam Assist. Level Three — Conditional Automation:Representing the next forefront in AV technology, level three vehicles can operate themselves under ideal conditions such as limited access highways. A driver is still required to be behind the wheel of a level-three vehicle, but they can take their hands off of it. Level Four — High Automation:At level four, vehicles can drive themselves without human interaction. Waymo,Alphabet’s autonomous vehicle division, has developed and is now testing level-four vehicles on both closed-track environments and public roads that can drive themselves in most conditions, and has now logged more than 5 million miles, making it the leader. Uber, meanwhile, has racked up 2 million miles as of December 2017. Level Five — Full Automation:At level five, a vehicle can drive itself on known and unknown roads and doesn’t require any human input. Such vehicles can operate under any road conditions and since they don’t need human input, they will be designed without steering wheels and pedals. Below isGeneral Motors'(NYSE:GM) Cruise AV, a fully autonomous model without a steering wheel or pedals that the company hopes to deploy next year.

    General Motors’ Cruise AV, which it hopes to deploy in 2019, does not have a steering wheel or pedals. Image sou

  • [By Keith Noonan, Chris Neiger, and Daniel Miller]

    To help our readers identify investments that offer protection against a potential downturn, as well as avenues to substantial capital appreciation, we put together a panel of Motley Fool investors and asked each member propose a stock they think presents long-term opportunity at a relative bargain price today, and to shed some light on why. Their picks: IBM (NYSE:IBM), General Motors (NYSE:GM), and Seagate Technology (NASDAQ:STX).

  • [By John Rosevear]

    Shares of General Motors (NYSE:GM) soared on Thursday after GM revealed that an important technology-investment fund controlled by Japanese telecom giant SoftBank Group (NASDAQOTH:SFTBF) has agreed to invest $2.25 billion in GM’s self-driving subsidiary.

  • [By Wayne Duggan]

    On this day nine years ago, General Motors Company (NYSE: GM) filed for Chapter 11 bankruptcy.

    Where The Market Was

    The Dow closed at 8,721.44. The S&P 500 traded at around 942.87. Today, the Dow is trading at 24,415.84 and the S&P 500 is trading at 2,705.27.

  • [By ]

    But what investors are overlooking are the fundamental risks to this logic. Corporate earnings are the lifeblood of the market, keep in mind. Higher oil prices have already translated into higher gas prices, which is a key risk to automakers such as Ford (F) and General Motors (GM) that have pivoted big-time to producing SUVs and trucks. Higher oil prices have already taken a toll on earnings for packaged food giants like Proctor & Gamble (PG) and Tyson Foods (TSN) . Now, each are staring at consumer price increases because it costs more to deliver their products to stores.

Top Performing Stocks For 2019: Camden Property Trust(CPT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Camden Property Trust (NYSE:CPT) was upgraded by analysts at TheStreet from a “c+” rating to a “b-” rating in a report released on Thursday.

  • [By Max Byerly]

    Amundi Pioneer Asset Management Inc. lifted its holdings in Camden Property Trust (NYSE:CPT) by 8.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 291,582 shares of the real estate investment trust’s stock after acquiring an additional 21,627 shares during the period. Amundi Pioneer Asset Management Inc. owned approximately 0.31% of Camden Property Trust worth $24,545,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Logan Wallace]

    Cryptaur (CURRENCY:CPT) traded up 2.6% against the US dollar during the 1-day period ending at 10:00 AM ET on June 14th. Cryptaur has a total market capitalization of $0.00 and $255,998.00 worth of Cryptaur was traded on exchanges in the last 24 hours. Over the last seven days, Cryptaur has traded 2.4% higher against the US dollar. One Cryptaur token can now be purchased for $0.0042 or 0.00000065 BTC on popular cryptocurrency exchanges including HitBTC and LATOKEN.

  • [By Ethan Ryder]

    Swiss National Bank reduced its position in Camden Property Trust (NYSE:CPT) by 5.8% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 451,000 shares of the real estate investment trust’s stock after selling 28,000 shares during the quarter. Swiss National Bank’s holdings in Camden Property Trust were worth $37,965,000 as of its most recent filing with the SEC.

  • [By Stephan Byrd]

    These are some of the news articles that may have impacted Accern Sentiment’s rankings:

    Get Camden Property Trust alerts:

    Camden Property Trust to Post Q3 2018 Earnings of $1.19 Per Share, DA Davidson Forecasts (CPT) (americanbankingnews.com) Camden Property Trust Forecasted to Earn FY2019 Earnings of $4.99 Per Share (CPT) (americanbankingnews.com) Camden Property Trust’s (CPT) CEO Ric Campo on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of CPT earnings conference call or presentation 4-May-18 3:00pm GMT (finance.yahoo.com) Camden: 1Q Earnings Snapshot (finance.yahoo.com)

    Several research firms have commented on CPT. BTIG Research increased their price target on shares of Camden Property Trust to $93.00 and gave the company a “buy” rating in a research report on Thursday, March 15th. Zacks Investment Research raised shares of Camden Property Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, March 20th. TheStreet lowered shares of Camden Property Trust from a “b” rating to a “c+” rating in a research report on Thursday, January 18th. Sandler O’Neill set a $97.00 price target on shares of Camden Property Trust and gave the company a “buy” rating in a research report on Tuesday, February 6th. Finally, BMO Capital Markets set a $94.00 price target on shares of Camden Property Trust and gave the company a “buy” rating in a research report on Monday, February 12th. Eight equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $90.64.

  • [By Stephan Byrd]

    Camden Property Trust (NYSE:CPT) announced a quarterly dividend on Friday, June 15th, RTT News reports. Stockholders of record on Friday, June 29th will be given a dividend of 0.77 per share by the real estate investment trust on Tuesday, July 17th. This represents a $3.08 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date of this dividend is Thursday, June 28th.

Top Performing Stocks For 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Performing Stocks For 2019: PVH Corp.(PVH)

Advisors’ Opinion:

  • [By ]

    In the mid-level, Boss said that Urban Outfitters (URBN) is recovering, along with Kohl’s Stores (KSS) . He also liked PVH (PVH) and Lululemon Athletica (LULU) .

  • [By Logan Wallace]

    Research analysts at Goldman Sachs Group initiated coverage on shares of PVH (NYSE:PVH) in a report released on Monday, The Fly reports. The brokerage set a “sell” rating on the textile maker’s stock.

  • [By ]

    Perhaps seeing the names of these companies begins to spark some memories. In short, clothing retailer PVH (NYSE: PVH) and beverage company Constellation Brands (NYSE: STZ) were taking heat over the rhetoric of a possible “Border Tax” — a tax on goods made overseas and imported and sold in the United States.

Top Performing Stocks For 2019: First Financial Northwest Inc.(FFNW)

Advisors’ Opinion:

  • [By Max Byerly]

    First Financial Northwest (NASDAQ:FFNW) will be announcing its earnings results on Tuesday, July 24th. Analysts expect the company to announce earnings of $0.26 per share for the quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Performing Stocks For 2019: Host Hotels & Resorts, Inc.(HST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Host Hotels and Resorts (HST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Host Hotels & Resorts (HST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Host Hotels & Resorts (NYSE:HST) had its price objective boosted by Stifel Nicolaus from $20.50 to $21.00 in a research note published on Thursday. They currently have a buy rating on the real estate investment trust’s stock.

Best Safest Stocks To Watch Right Now

How to play the turnaround in the Brazilian economy

Investing in emerging markets always has a heightened amount of risk associated with it. However, large and mid-cap stocks can help mitigate the heightened amount of risk. This is why I believe that the iShares MSCI Brazil Index (EWZ) is the safest way to play the turnaround in the Brazilian economy. The MSCI Brazil 25/50 Index is designed to measure the performance of the large and mid cap segments of the Brazilian market. As of February 1st, 2018 EWZ had the following sector weightings in its portfolio:

A rebounding economy and an uptick in commodity prices bode well for the fund’s top holdings.

Best Safest Stocks To Watch Right Now: Stantec Inc(STN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Stantec (NYSE: STN) and VSE (NASDAQ:VSEC) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Shane Hupp]

    ATKINS WS GBP0.005 (OTCMKTS: WATKF) and Stantec (NYSE:STN) are both mid-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Stantec (STN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Safest Stocks To Watch Right Now: Live Ventures Incorporated(LIVE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Live Stars (CURRENCY:LIVE) traded up 2.3% against the dollar during the 24 hour period ending at 23:00 PM Eastern on June 25th. Over the last seven days, Live Stars has traded down 10.1% against the dollar. One Live Stars token can currently be bought for approximately $0.0249 or 0.00000400 BTC on major exchanges. Live Stars has a total market cap of $990,922.00 and $25,651.00 worth of Live Stars was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Best Safest Stocks To Watch Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Safest Stocks To Watch Right Now: Xinyuan Real Estate Co Ltd(XIN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Mixin (XIN) is a proof-of-stake (PoS) token that uses the SHA256 hashing algorithm. It launched on October 2nd, 2017. Mixin’s total supply is 1,000,000 tokens and its circulating supply is 438,115 tokens. Mixin’s official message board is mixin.one/logs. Mixin’s official Twitter account is @XIN_Foundation and its Facebook page is accessible here. The official website for Mixin is mixin.one.

  • [By Shane Hupp]

    Xinyuan Real Estate Co., Ltd. (NYSE:XIN) declared a quarterly dividend on Wednesday, May 30th, RTT News reports. Stockholders of record on Monday, June 11th will be given a dividend of 0.05 per share by the financial services provider on Friday, June 22nd. This represents a $0.20 annualized dividend and a dividend yield of 3.74%.

Top Low Price Stocks To Invest In Right Now

What happened

Shares of Rogers Corp. (NYSE:ROG) gained 19.9% in April 2017, according to data from S&P Global Market Intelligence.

So what

The company reported first-quarter results on April 26, sending share prices nearly 12% higher the next day. Rogers saw 27% year-over-year sales growth and 79% higher earnings, leaving analyst estimates far behind in both cases.

A Rogers engineer, hard at work on next-generation battery materials. Image source: Rogers.

Now what

Rogers shares have now gained 72% over the last 52 weeks, trading steadily near all-time highs. The maker of specialized materials used in battery systems and wireless antennas has consistently delivered solid earnings surprises over the last three years, often coupled with equally strong revenue wins.

This company is poised to continue making a killing in several emerging markets, including the Internet of Things and automotive computing. Best of all, Rogers is winning competitive contracts without resorting to pricing discounts. Trailing operating margins have increased from 12.4% to 14.2% over the last four quarters. In other words, clients are choosing Rogers over rival materials providers for other reasons than low prices, such as product quality and dependable ordering and delivery processes.

Top Low Price Stocks To Invest In Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

Top Low Price Stocks To Invest In Right Now: TechTarget, Inc.(TTGT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TechTarget (NASDAQ:TTGT) Director Leonard P. Forman sold 63,862 shares of the business’s stock in a transaction dated Tuesday, May 15th. The shares were sold at an average price of $23.59, for a total transaction of $1,506,504.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Top Low Price Stocks To Invest In Right Now: Farmers National Banc Corp.(FMNB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Farmers National Banc (NASDAQ:FMNB)‘s stock had its “hold” rating reissued by equities researchers at Keefe, Bruyette & Woods in a note issued to investors on Thursday. They presently have a $18.00 price target on the bank’s stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 21.62% from the company’s previous close.

Top Low Price Stocks To Invest In Right Now: Neovasc Inc.(NVCN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Neovasc Inc. (NASDAQ: NVCN) fell about 21% Wednesday to post a new 52-week low of $0.26 after closing at $0.33 on Tuesday. The 52-week high is $2.12. Volume of about 7.3 million was around 7 times the daily average. The medical device maker had no specific news.

  • [By Max Byerly]

    Neovasc Inc. (NASDAQ:NVCN) (TSE:NVC) was the target of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 74,020,430 shares, a growth of 55.3% from the April 13th total of 47,655,636 shares. Approximately 83.5% of the company’s shares are short sold. Based on an average daily volume of 87,826,510 shares, the short-interest ratio is presently 0.8 days.